Acumen Pharmaceuticals, Inc.
ABOS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001576885
No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Acumen Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 73 | 1 | 80 | +8 |
| Shares | 43.6M | 5 | 42.5M | −1.07M (−2.5%) |
| Value | $107.7M | $13 | $73.2M | −$34.5M (−32.1%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 94,294 | $162.2K | 0.03% |
| Atom Investors LP | 33,678 | $57.9K | 0.01% |
| Marex Group plc | 33,300 | $57.3K | 0.00% |
| Verition Fund Management LLC | 19,445 | $33.4K | 0.00% |
| Intech Investment Management LLC | 18,847 | $32.4K | 0.00% |
| Pinnacle Associates Ltd | 18,020 | $31.0K | 0.00% |
| Clune & Associates, Ltd. | 16,500 | $28.4K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 14,731 | $25.3K | 0.00% |
| JustInvest LLC | 12,894 | $22.2K | 0.00% |
| Squarepoint Ops LLC | 11,815 | $20.3K | 0.00% |
| ProShare Advisors LLC | 11,812 | $20.3K | 0.00% |
| Integrated Wealth Concepts LLC | 10,100 | $17.4K | 0.00% |
| BNP Paribas Arbitrage, SA | 7,017 | $12.1K | 0.00% |
| Russell Investments Group, Ltd. | 1,237 | $2.13K | 0.00% |
| Simplex Trading, LLC | 1,191 | $2.00K | 0.00% |
| SBI Securities Co., Ltd. | 440 | $757 | 0.00% |
Sold out (8)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| TD Asset Management Inc | 139,206 | $345.2K |
| Manufacturers Life Insurance Company, The | 52,333 | $129.8K |
| Virtu Financial LLC | 22,255 | $55.0K |
| Susquehanna Portfolio Strategies, LLC | 21,903 | $54.3K |
| Jump Financial, LLC | 21,200 | $52.6K |
| Acadian Asset Management LLC | 18,643 | $46.0K |
| Fortitude Advisory Group L.L.C. | 13,300 | $33.0K |
| Capital Performance Advisors LLP | 52 | $129 |
Not filed for Q4 2024 yet (1)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Planning Capital Management Corp | 5 | $13 |